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Genes cut across systems
Neurologists should think “heart” and cardiologists “brain”
Despite a strong association with a history of uncon-
trolled convulsions, until recently, mystery surrounded
sudden unexpected death in epilepsy (SUDEP). This is
when a person with epilepsy, usually a young adult,
dies suddenly without a structural or toxicologic cause
for death identified.1 The Mortality in Epilepsy Mon-
itoring Unit Study (MORTEMUS) has partially dis-
pelled this mystery. Deaths occurred, in the absence of
timely assistance, in the aftermath of a convulsion with
postictal, centrally mediated severe respiratory and car-
diac dysfunction. Hypoventilation and bradyarrhyth-
mias were seen, with asystole usually occurring after
apnea.2 Much has been made of respiratory compro-
mise in the context of postictal coma, usually in the
setting of generalized EEG suppression, when the indi-
vidual has impaired ability to improve oxygenation by
correcting position or enhancing respiration despite
hypercapnia and hypoxia.3 This observation ties in
with conclusions of a recent review of arrhythmias
and seizures that found that postictal arrhythmias
mostly occurred following convulsions and often cor-
related with (near) SUDEP.4 The MORTEMUS
study showed a clear interrelation between respiratory
and cardiac dysfunction.3
Genetic predisposition, particularly, but not exclu-
sively, to sudden cardiac death, has long seemed plau-
sible as a contributor in at least some SUDEP cases.
Such predisposition not only accounts for disorders
such as long QT syndrome (LQTS), with sudden
death presenting as early as in utero, but also some
acquired disorders. Cardiac arrest following a first ST
elevation myocardial infarction, for example, is more
common with a family history of sudden cardiac death,
and genetic susceptibility is implicated in drug-induced
long QT.5 A previous review explored the potential of
coexisting genetic liability to cardiac arrhythmias as
a factor in SUDEP, but lacked bridging clinical evi-
dence between cardiac inherited gene determinants
and SUDEP.6 Recent studies have begun to fill that
gap, although more evidence is needed.
In an Australian coronial study of 68 SUDEP
cases, researchers identified previously reported
amino acid changing variants in the 3 most common
LQTS genes (LQTS1, KCNQ1 [KV7.1]; LQTS2,
KCNH2 [HERG/KV11.1]; LQTS3, SCN5A [NaV1.5])
in 6 (13%) cases, 2 in KCNH2 and 4 SCN5A.7 More
recently, the group investigated 61 SUDEP cases.8 They
performed exome-based analysis of rare variants and
screened cardiac arrhythmia, respiratory control, and epi-
lepsy genes for variants predicted to be pathogenic with
a frequency of,0.1%. They found variants in 28 of the
61 (46%), including known LQTSmutations in 4 (7%)
and candidate variants in genes potentially predisposing
to cardiac arrhythmia in 9 (15%), with 1 mutation each
in SCN5A and KCNQ1, and 2 mutations and 1 candi-
date variant in KCNH2. Fifteen (25%) also had muta-
tions in known epilepsy genes, 6 in DEPDC5. This
study thus showed that a sizeable proportion of SUDEP
cases had relevant mutations in cardiac arrhythmia and
epilepsy genes. A comparator group of people with epi-
lepsy in a similar age group dying of other causes would
be of interest.
In this issue of Neurology®, Auerbach et al.9 report
on seizures, arrhythmias, and biomarkers using their
LQTS Registry in a large cohort of 965 genetically
confirmed LQTS cases (LQTS[1]) comparing them
to those without genetic LQTS (LQTS[2]). This fol-
lows from an earlier smaller study reporting more fre-
quently reported seizures in LQTS2 than other LQTS
subtypes.10 Compared to LQTS(2), in the current
study, more LQTS1, LQTS2, and LQTS(1) partic-
ipants were classified as having seizures. In LQTS(1)
cases, a strong positive correlation was found between
QTc duration and seizure history. Genotype influ-
enced clinical presentation. LQTS2 mutations in the
KCNH2 pore domain positively predicted both ar-
rhythmias and seizures, while mutations in the cyclic
nucleotide binding domain conferred a negative risk of
seizures, but not arrhythmias. LQTS2 and sex also
both predicted seizures independently. A history of
seizures was the strongest independent predictor of
arrhythmias.
This study adds important observations on the
relationship between seizures and LQTS and poten-
tial overlap between genetic cardiac arrhythmias and
epilepsy. Seizure manifestation, however, may still
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have been a reflection of more severe arrhythmias rather
than epilepsy. The authors defined a seizure history as
a personal history of seizures or epilepsy or antiseizure
medication. Epilepsy phenotyping relied on self or phy-
sician reporting and not on systemic ascertainment. The
correlation between seizure history and arrhythmias may
be explained by genetic factors causing both cardiac
disease and epilepsy but may also reflect a misdiagnosis
of epilepsy. b-Blockers, however, reduced the risk of
arrhythmias in genotype-positive cases but not seizure
risk. This and the differing associations between gen-
otypes and seizure risk strongly argue in favor of neu-
rocardiac disease, at least in some cases.
These and other studies provide accumulating evi-
dence that in some who experience SUDEP, mutated
genes coexpressed in the heart and the brain lead to epi-
lepsy and arrhythmia. In others, however, there may be
coincidental predisposition to cardiac death (whether
monogenic or polygenic), which may be more likely
to manifest in the context of uncontrolled convulsions.
The Australian studies suggest these categories repre-
sent an important minority of SUDEP cases.
In addition to prevention of convulsions and assis-
tance at the time of a seizure, we now have another
potential avenue for SUDEP prevention, one as yet
unexplored. Genes do not recognize the arbitrary divi-
sions of specialization today. Neurologists must consider
the heart and cardiologists the brain. Family studies,
with a good yield in sudden cardiac death, are needed
in SUDEP. We will need prolonged EEG recordings
of selected cases of LQTS to clarify with more cer-
tainty when seizures in LQTS are due to epilepsy
or epilepsy mimics. This chapter on genetic predis-
position to SUDEP is not yet complete, but this
important study by Auerbach and colleagues adds
new insight to knowledge.
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